In-home COPD management program cuts 30-day acute-care readmissions
By
Alicia Lasek (f3)
Jun 29, 2022
Thirty-day readmission rates were 12% for post-acute COPD participants in an at-home pulmonary rehab program, and 22% for those without the intervention, a new study finds.
Bone health intervention cuts fracture risk in men treated for prostate cancer: study
By
Alicia Lasek
Apr 05, 2022
Early intervention with bone mineral density screening may help prevent major fractures in older men treated with androgen deprivation therapy, investigators say.
Reform policies ‘double down’ on decades-long failures, LTC physicians warn
By
Danielle Brown
Mar 07, 2022
The Biden administration’s approach toward nursing home reform uses the unsuccessful and “punitive” tactics that haven’t proved to advance quality for years, according to a top industry group.
FDA expands use of remdesivir to skilled nursing, other non-hospital settings
By
Alicia Lasek
Jan 25, 2022
Remdesivir, the first FDA-approved COVID-19 drug, now can be used in adult and pediatric patients with mild-to moderate COVID-19 illness at high risk of progressing to severe disease, the agency has announced.
Monoclonal antibodies excel in treating COVID-19 breakthrough cases, Mayo Clinic says
By
Alicia Lasek
Nov 19, 2021
Monoclonal antibody treatment lowers the odds of hospitalization by 77% in patients with COVID-19 breakthrough infections, investigators say. These SARS-CoV-2 reinfections have become more common in long-term...
Agency staff more prevalent but less dependable: survey
By
Danielle Brown
Oct 07, 2021
Staffing struggles continue at historic levels, according to a new national survey of long-term care providers, some of whom acknowledge they are being forced to turn to fewer options to cover their workforce...
An antibody cocktail that halts disease progression in sick COVD-19 patients has been shown to prevent the disease altogether in healthy people who live in close contact with an infected person, the drugmaker...
Becerra orders CMS to rethink $22 Medicare Part B premium price hike tied to Aduhelm
By
Alicia Lasek
Jan 11, 2022
With the 50% price drop of Aduhelm on January 1, there is good reason for CMS to reassess a hefty proposed premium hike for 2022, the U.S. health secretary said. On Wednesday, CMS is expected to announce...
COVID ‘breakthrough’ outbreak affects one quarter of residents at French nursing home
By
Alicia Lasek
Sep 15, 2021
In a facility with a 97% resident vaccination rate, the large number of infections shows that a shot alone is not enough to protect the frail elderly from SARS-CoV-2, researchers contend.
66 percent of nursing home residents given antibiotics during stays, researchers report
By
Alicia Lasek
Apr 09, 2023
Results from a long-term study of Medicare Part D data shed light on antibiotic prescribing prevalence, the most common drug types and rate of therapy days for U.S. nursing home residents.